Carbon-monoxide-releasing molecules and therapeutic applications thereof

US11420994B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11420994-B2
Application numberUS-201716487402-A
CountryUS
Kind codeB2
Filing dateNov 15, 2017
Priority dateNov 16, 2016
Publication dateAug 23, 2022
Grant dateAug 23, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Carbon monoxide-releasing organic molecules are described herein. The molecules can be synthesized prior to administration (e.g., ex vivo) or formed in vivo. In those embodiments where the molecules are formed in vivo, reactants are administered under physiological conditions and undergo a cycloaddition reaction to form a product which releases carbon monoxide. In applying such reactions for therapeutic applications in vivo, the cycloaddition and CO release typically occur only under near-physiological or physiological conditions. For example, in some embodiments, the cycloaddition reaction and/or release of carbon monoxide occur at a temperature of about 37° C. and pH of about 7.4. Pharmaceutical compositions and methods for release carbon monoxide are also described.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound selected from the group consisting of: or a pharmaceutically acceptable salt thereof, wherein Ph represents phenyl and Ms represents methanesulfonyl. 2. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable excipient.

Assignees

Inventors

Classifications

  • having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] in the acid moiety · CPC title

  • having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton · CPC title

  • with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring · CPC title

  • Acyclic radicals, substituted by carbocyclic rings · CPC title

  • A61P9/02Primary

    Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11420994B2 cover?
Carbon monoxide-releasing organic molecules are described herein. The molecules can be synthesized prior to administration (e.g., ex vivo) or formed in vivo. In those embodiments where the molecules are formed in vivo, reactants are administered under physiological conditions and undergo a cycloaddition reaction to form a product which releases carbon monoxide. In applying such reactions for th…
Who is the assignee on this patent?
Univ Georgia State Res Found
What technology area does this patent fall under?
Primary CPC classification A61P9/02. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).